Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers smokers

Epidemiology

Volumn 11, Issue 3, 2000, Pages 280-284

  Dufouil, Carole ^a   Tzourio, Christophe ^a   Brayne, Carol ^b   Berr, Claudine ^a   Amouyel, Philippe ^a   Alpérovitch, Annick ^a  

^a INSERM   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Aged; Alcohol drinking; Apolipoprotein E; Cognitive decline; Cohort study; Smoking

Indexed keywords

ALCOHOL; APOLIPOPROTEIN E;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RISK FACTOR; TOBACCO;

AGED; ALCOHOL DRINKING; APOLIPOPROTEINS E; COGNITION DISORDERS; DEMENTIA; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; SMOKING;

EID: 0034050769     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200005000-00009     Document Type: Article

References (20)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
2. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342: 697-699.
3. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
4. Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, Christensen H, Croft L, Jacomb PA. Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-1390.
5. Yaffe K, Cauley J, Sands L, Browner W. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arch Neurol 1997;54:1110-1114.
6. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction of Alzheimer's disease. Ann Neurol 1995;38:6-14.
7. Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Crain B, Tang MX, Phelps CH. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N Engl J Med 1998;338:506-511.
8. Slooter AJ, Cruts M, Kalmjin S, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 1998;55:964-968.
9. Desmond DW, Tatemichi TK, Myunghee P, Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993;50:162-166.
10. Breteler MMB, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, van Harskamp F, Tanghe HL, de Jong PT, van Gijn J, Hofman A. Cerebral white matter lesions, vascular risk factors and cognitive function in a population based study: the Rotterdam Study. Neurology 1994;44:1246-1252.
11. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A. A 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
12. Dufouil C, Ducimetiere P, Alpérovitch A. Sex difference for association between alcohol consumption and cognitive performance. Am J Epidemiol 1997;146:405-412.
13. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R, Renaud S, Breteler MB. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol 1997;153: 185-192.
14. Ott A, Slooter JC, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, van Duijn CM, Breteler MM. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998;351:1840-1843.
15. Van Duijn C, Havekes LM, Van Broeckhoven C, de Knijff P, Hofman A. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ 1995;310:627-631.
16. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1977;1:385-401.
17. Fuhrer R, Rouillon F. La version française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l'échelle d'auto-évaluation (in French). Psychiatr Psychobiol 1989;4:163-166.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989;298:789-794.
20. Toupance P, Godelle B, Gouyon PH, Schächter F. A model for antagonistic pleiotropic gene action for mortality and advanced age. Am J Hum Genet 1998;62:1525-1534.